Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LOQTEQ Distal Lateral Femur Plate 4.5 System

K-Number: K210043 · 2021-03-03

ApplicantAap Implantate AG
Decision Date2021-03-03
Product CodeHRS
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

LOQTEQ Distal Lateral Femur Plate 4.5 System is a medical device manufactured by Aap Implantate AG. It received FDA 510(k) clearance on 2021-03-03 under approval number K210043. The device is classified under product code HRS. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LOQTEQ Distal Lateral Femur Plate 4.5 System?

LOQTEQ Distal Lateral Femur Plate 4.5 System is a medical device that received FDA 510(k) clearance on 2021-03-03. It is manufactured by Aap Implantate AG. The 510(k) number is K210043.

When was LOQTEQ Distal Lateral Femur Plate 4.5 System approved by the FDA?

LOQTEQ Distal Lateral Femur Plate 4.5 System received FDA 510(k) clearance on 2021-03-03, under approval number K210043.

What company makes LOQTEQ Distal Lateral Femur Plate 4.5 System?

LOQTEQ Distal Lateral Femur Plate 4.5 System is manufactured by Aap Implantate AG.

What is the FDA product code for LOQTEQ Distal Lateral Femur Plate 4.5 System?

The FDA product code for LOQTEQ Distal Lateral Femur Plate 4.5 System is HRS.

Related Clinical Trials

NCT07616050 Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients NOT_YET_RECRUITING NCT07211035 Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1) RECRUITING NCT07431723 Creation of Compression Anastomosis Using the GT Metabolic Magnet System RECRUITING NCT05762055 Prospective Comparative Analysis of ACDF vs Fusion Interbody Cages With nanoLOCK Osseointegrative Technology ENROLLING_BY_INVITATION NCT06977035 Nerve Conduction Study for Assessment of Peripheral Neuropathy in Rheumatoid Arthritis Patients on the Janus Kinase Inhibitor Baricitinib RECRUITING NCT07571486 Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis. NOT_YET_RECRUITING

Other Devices by Aap Implantate AG

K161696aap LOQTEQ® Distal Lateral Humerus Plate 2.7/3.5 K161747LOQTEQ® VA Distal Tibia Plate System: LOQTEQ® VA Distal Medial Tibia Plate 3.5; LOQTEQ® VA Distal Anterolateral Tibia Plate 3.5; LOQTEQ® VA Distal Fibula Plate 2.7/3.5 K161703LOQTEQ Distal Fibula Plate 3.5, Cancellous Screw 4.0, Washer K153034aap LOQTEQ VA Radius Set 2.5 K182818LOQTEQ VA Calcaneus Plate 3.5 K182785LOQTEQ VA Foot Plates 2.5

View all 11 devices →

Related Devices (Code: HRS)

K163086VLP MINI-MOD 2.0mm Column PlatesSmith & Nephew, Inc. K162829Medline UNITE® Ankle Fracture Plating SystemMedline Industries, Inc. K162974Biomet Microfixation RibFix Blu Thoracic Fixation SystemBiomet Microfixation K163007Biomet Microfixation SternaLock 360 Sternal Closure SystemBiomet Microfixation K161696aap LOQTEQ® Distal Lateral Humerus Plate 2.7/3.5Aap Implantate AG K161747LOQTEQ® VA Distal Tibia Plate System: LOQTEQ® VA Distal Medial Tibia Plate 3.5; LOQTEQ® VA Distal Anterolateral Tibia Plate 3.5; LOQTEQ® VA Distal Fibula Plate 2.7/3.5Aap Implantate AG

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑